Linked Life Data

21351823

Source:http://linkedlifedata.com/resource/pubmed/id/21351823

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-15
pubmed:abstractText
Levodopa is the mainstay of Parkinson's disease (PD) treatment, but is often eventually associated with disabling motor complications in patients with advanced PD. The inability of perorally administered levodopa to provide more physiologic continuous dopaminergic stimulation (CDS) is a leading hypothesis to explain these complications.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1473-4877
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
907-19
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
pubmed:affiliation
Department of Neurology, Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH 44122, USA. fernanh@ccf.org
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't